Iterum Therapeutics Plc
ITRM
Revenue
37.00k
▼-202.00k▼-84.52%
3 Months ChangeAssets
14.17M
▼-5.45M▼-27.78%
3 Months ChangeLiabilities
25.09M
▼-688.00k▼-2.67%
3 Months ChangeFree Cash Flow
-15.06M
▼-3.40M▼-29.17%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-11-01
Form 8-K
ID: 0000950170-24-120154
2024-10-25
Form 8-K
ID: 0000950170-24-117270
2024-10-15
Form 8-K
ID: 0000950170-24-114467
2024-10-08
Form 8-K
ID: 0000950170-24-113413
2024-10-04
Form 8-K
ID: 0000950170-24-112977
2024-08-14
Form 10-Q
ID: 0000950170-24-096653
2024-08-14
Form 8-K
ID: 0000950170-24-096649
2024-08-06
Form 8-K
ID: 0000950170-24-092011
2024-07-22
Form 8-K
ID: 0000950170-24-085057
2024-06-26
Form 8-K
ID: 0000950170-24-077963